By Emmy Lucas
The women's health app Flo's valuation increased to $800 million after its series B funding round.
read more
By Kyle LaHucik
NYU researchers reported that in the early days of the pandemic, they found certain autoimmune antibodies in hospitalized patients that correlated to more severe COVID-19 disease. They believe their findings could be used to help hospitals determine how best to treat patients admitted with COVID-19.
read more
By Beth Snyder Bulik
Notoriously laid-back NFL star Rob Gronkowski is looking to score for the telehealth and medication delivery service Hims & Hers Health with messages on social media, digital, TV and streaming audio.
read more
By Emmy Lucas
OrbiMed Advisors and Lilly Asia Ventures are two key players pouring money into RNA-targeting technology via ADARx Pharmaceuticals’ $75 million series B round. The funding will take the San Diego-based biotech’s growing pipeline of RNA-targeting therapeutics into the clinic, ADARx said in a statement on Wednesday.
read more
By Anastassia Gliadkovskaya
The American Board of Family Medicine, the American Board of Internal Medicine and the American Board of Pediatrics announced in a joint statement that board-certified physicians may lose their license if they spread misleading information about the COVID-19 vaccines.
read more
By Eric Sagonowsky
Only months after Amgen kicked off its U.S. launch for cancer drug Lumakras, the med is set to make its debut in England.
read more
By Conor Hale
Novocure hopes to put forward its therapy as a first-line option for unresectable or metastatic liver cancer.
read more
By Robert King
HHS announced a $25.5 billion distribution of COVID-19 relief funds, the first distribution announcement in nearly a year.
read more
By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner
The CDC says unvaccinated Americans are 11 times more likely to die than those who are vaccinated. Moderna's shot is slightly more effective at preventing hospitalizations. Plus more.
read more
By Paige Minemyer
Medicare Advantage insurer SCAN Health Plan will expand its coverage options into Arizona and Nevada for the 2022 plan year, the company announced Thursday.
read more
By Kyle LaHucik
Former FDA Commissioner Stephen Hahn is joining YourBio Health as interim chief medical officer. Gilead's global head of liver diseases, Tram Tran, M.D., will be Glympse Bio's first chief medical officer. And Orchard Therapeutics picks an apple from Novartis' field, snagging cell and gene therapies leader Nicoletta Loggia, Ph.D., as chief technical officer.
read more
